PATENT CLAIM ANALYSIS

Application Number: 16071649
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["424", "206100"]

Abstract:
The invention relates to compounds having the structure of formula (I) which can be used for the treatment of or against influenza infections.

Claim (Index 15):
A method of inhibiting replication of influenza virus(es) in a biological sample, said method comprising administering to the biological sample a compound of formula (I): a stereo-isomeric form, a pharmaceutically acceptable salt, solvate or polymorph thereof, wherein X is selected from \u2014CF or N; Y is selected from N, \u2014CF, \u2014C\u2014Cl, \u2014C\u2014CN or \u2014C\u2014CH 3 ; R 1  is selected from \u2014H, \u2014CH 3 , \u2014COOH, \u2014CF 3 , -cyclopropyl, \u2014CONH 2 , \u2014CONH(C 1-3 alkyl),\n or \u2014CON(C 1-3 alkyl) 2 ; \n Q is selected from N or O; and \n R 2  is a heterocycle optionally substituted by halogen, cyano, C 1-3 alkyl, hydroxyl, amino, methoxy, \u2014COOH, \u2014CF 3  or cycloalkyl.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 95.0
- Lexical Diversity: 1.08333
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15779468', '15501730', '15509474', '16068315', '15177546']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7269141272248332
- 35 USC 102 Novelty (BERT): 0.5120572138354027
- Combined Prediction Score: 0.7054284358858902
- Mean Citation Score: 292.1431800000001
- Max Citation Score: 316.5471
- Similarity Product: 267.82517199110987

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test